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Biosensing devices comprised of carbon nanotubes and nanofibers have been developed for 
astronaut crew point-of-care.  Their inherent nanometer scale, high conductivity, wide potential 
window, good biocompatibility and well-defined surface chemistry make them ideal candidates 
as biosensor electrodes.  Here, we report two studies using carbon nanotube and carbon 
nanofiber electrodes for biomedical applications.  First, a 3x3 electrode device, with each 
electrode containing 40,000 carbon nanofiber nanoelectrodes was fabricated on silicon using 
traditional microfabrication processing.  The device was demonstrated as a multiplexed 
immunosensor for simultaneous, label-free detection of cardiac troponin-I, C-reactive protein 
and myoglobin.  Antibodies specific to cardiac troponin-I, C-reactive protein and myoglobin were 
covalently bound to the CNF surface and were characterized using electrochemical impedance 
spectroscopy and differential pulse voltammetry.  Each step of the modification process resulted 
in changes in resistance to charge transfer due to the changes at the electrode surface upon 
antibody immobilization and binding to the specific cardiac protein.  The real-time label free 
detection of the three cardiac markers from pure components and mixtures was demonstrated 
with high sensitivity, down to 0.2 ng/mL, and good selectivity.  Detection in human blood serum 
did not present false positives from non-specific protein adsorption.  More recently, this 
detection scheme has been applied to inkjet printed carbon nanotube electrodes on Kapton and 
paper.  Printed devices have several unique advantages including simple and inexpensive 
fabrication.  The results demonstrate that these sensors can serve a miniaturized, low cost device 
for detection of proteins in complex mixtures making this platform a good candidate for early 
stage diagnosis of myocardial infarction.  Future inkjet printed devices can be fabricated have the 
added advantage in their suitability to be manufactured in an in-space, microgravity 
environment. 
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